share_log

424B5: Prospectus

424B5: Prospectus

424B5：募資說明書
美股SEC公告 ·  07/22 11:27

Moomoo AI 已提取核心訊息

60 Degrees Pharmaceuticals, Inc. has updated its prospectus supplement on July 22, 2024, to reflect an increase in the maximum aggregate gross sales price of its common stock offered through an At the Market Issuance Sales Agreement with WallachBeth Capital LLC. The increase adjusts the sales cap from the previously registered $1,253,603 to $1,774,640. As of the filing date, 3,969,076 shares have been sold under the agreement, amounting to an aggregate gross sales price of $1,197,073.32. The company's common stock is traded on The Nasdaq Capital Market under the symbol 'SXTP', with a closing sale price of $0.271 per share on July 19, 2024. The ATM Offering terms remain unchanged, and the Sales Agreement is still in effect. The company's market value of outstanding common stock held by non-affiliates is approximately $5,154,331, based on a share price of $0.351 as of June 7, 2024. The company has emphasized the significant risks associated with investing in its common stock, as detailed in the 'Risk Factors' section of the Prospectus Supplement and Base Prospectus, and other SEC filings.
60 Degrees Pharmaceuticals, Inc. has updated its prospectus supplement on July 22, 2024, to reflect an increase in the maximum aggregate gross sales price of its common stock offered through an At the Market Issuance Sales Agreement with WallachBeth Capital LLC. The increase adjusts the sales cap from the previously registered $1,253,603 to $1,774,640. As of the filing date, 3,969,076 shares have been sold under the agreement, amounting to an aggregate gross sales price of $1,197,073.32. The company's common stock is traded on The Nasdaq Capital Market under the symbol 'SXTP', with a closing sale price of $0.271 per share on July 19, 2024. The ATM Offering terms remain unchanged, and the Sales Agreement is still in effect. The company's market value of outstanding common stock held by non-affiliates is approximately $5,154,331, based on a share price of $0.351 as of June 7, 2024. The company has emphasized the significant risks associated with investing in its common stock, as detailed in the 'Risk Factors' section of the Prospectus Supplement and Base Prospectus, and other SEC filings.
60度藥品公司已在2024年7月22日更新其招股書補充，以反映其通過與WallachBeth Capital LLC達成的一項市場發行銷售協議所提供的普通股最大總銷售價格的增加。此次增加將銷售額上限從之前註冊的1253603美元調整到1774640美元。根據文件提交日期，在該協議下已銷售3969076股，總計銷售價格爲1197073.32美元。該公司的普通股在納斯達克股票市場上以'SXTP' 的代碼進行交易，2024年7月19日的收盤價爲每股0.271美元。市場發行的條款保持不變，銷售協議仍在生效。截至2024年6月7日，公司非附屬股東持有的普通股市值約爲5154331美元，股價爲0.351美元。該公司強調了投資其普通股所涉及的重大風險，詳見招股書補充和基礎招股書中的‘風險因素’章節以及其他SEC的資料。
60度藥品公司已在2024年7月22日更新其招股書補充，以反映其通過與WallachBeth Capital LLC達成的一項市場發行銷售協議所提供的普通股最大總銷售價格的增加。此次增加將銷售額上限從之前註冊的1253603美元調整到1774640美元。根據文件提交日期，在該協議下已銷售3969076股，總計銷售價格爲1197073.32美元。該公司的普通股在納斯達克股票市場上以'SXTP' 的代碼進行交易，2024年7月19日的收盤價爲每股0.271美元。市場發行的條款保持不變，銷售協議仍在生效。截至2024年6月7日，公司非附屬股東持有的普通股市值約爲5154331美元，股價爲0.351美元。該公司強調了投資其普通股所涉及的重大風險，詳見招股書補充和基礎招股書中的‘風險因素’章節以及其他SEC的資料。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間